WASHINGTON (AP) — Gilead Science Inc.'s earnings tumbled 17 percent in first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut into sales.

Topics:  washington ap     gilead science inc   c   sales   
BING NEWS:
  • Gilead: Q1 Earnings Snapshot
    The HIV and hepatitis C drugmaker posted revenue of $6.69 billion in the period, also beating Street forecasts. Ten analysts surveyed by Zacks expected $6.33 billion. Gilead expects full-year ...
    04/24/2024 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News